White paper
How biopharma is digitally transforming to accelerate development
The 2025 Benchling Development Summit gathered over 40 senior leaders from across biopharma to discuss the future of drug development. With growing pressure to accelerate clinical timelines and translate breakthroughs into therapies, leaders reflected on shared challenges while highlighting actionable paths forward.
This report, authored by Axendia, distills the key themes from those conversations—framed around a central question: How can we digitally transform the lab to accelerate innovation, improve efficiency, and deliver therapies to patients faster?
In this report, you’ll learn:
How biopharma leaders are reinventing development with digital-first strategies.
How Merck unlocked 10x efficiency by modernizing vaccine bioanalysis.
Where AI and unified data are already transforming the future of regulated labs.
View white paper
Join over 200,000 scientists using Benchling to power their biotech R&D
